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Chronic venous disease progression and
modification of predisposing factors
Theodoros I. Kostas, MD,a Christos V. Ioannou, MD,a Ioannis Drygiannakis, MD,b
Efstratios Georgakarakos, MD,a Christos Kounos, MD,a Dimitrios Tsetis, MD,c and
Asterios N. Katsamouris, MD,a Heraklion, Crete, Greece
Aim: This study evaluated long-term characteristics of chronic venous disease (CVD) progression and its correlation with
the modification of specific risk factors.
Methods: The contralateral limb of 73 patients (95% women; mean age, 48  12 years) undergoing varicose vein
surgery was prospectively evaluated using physical and color duplex examination and classified by CEAP. After 5
years of follow-up, development of new sites of reflux among the contralateral, preoperatively asymptomatic limbs
and modification of predisposing factors, including prolonged orthostatism, obesity, estrogen therapy (ET),
multiparity, and elastic stockings use (ESU), were assessed. Data were analyzed with Pearson 2, t test, binary
logistic regression, and Spearman .
Results: Forty-eight new sites of reflux (superficial system, 37; perforators, 5; deep veins, 6) were revealed in 38 limbs
(52%). CEAP scores significantly deteriorated: clinical, 2.2  0.5 from 0.1  0.03 (P < .01); anatomic, 3.8  1.2 from
2.6  2.5 (P < .05); disability, 1.9  0.7 from 0 (P < .01); and severity, 7.9  2.4 from 2.7  2.2 (P < .01). Patient
compliance to predisposing factor modification was low; no change was observed during follow-up (orthostatism, P .9;
obesity, P 0.7; ET, P .9; multiparity, P .4; ESU, P .3). CVD progression was significantly lower in patients who
controlled orthostatism vs those who maintained orthostatism or initiated it (P < .001) and in patients who controlled
preoperative obesity vs those who became obese or maintained obesity (P < .001). Non-ESU patients had a significantly
higher incidence of CVD progression vs those who started ESU or continued during the study (P < .001). By binary
logistic regression analysis, orthostatism (P  .002; B coefficient value [BCV]  1.745), obesity (P  .009; BCV 
1.602), and ESU (P  .037; BCV  0.947) were independent predictive factors for CVD progression, whereas
multiparity (P  .174) and ET (P  .429) were not.
Conclusions: In about half of patients with unilateral varicosities, CVD developed in the contralateral initially asymp-
tomatic limb in 5 years. CVD progression consisted of reflux development and clinical deterioration of the affected limbs.
Obesity, orthostatism, and noncompliance with ESU were independent risk factors for CVD progression, but ET and
multiparity were not. Maintenance of a normal body weight, limitation of prolonged orthostatism, and systematic ESU
may be recommended in patients with CVD to limit future disease progression. (J Vasc Surg 2010;51:900-7.)Chronic venous disease (CVD) is one of the common-
est vascular disorders.1 However, only a few longitudinal
studies have been reported on the natural history of primary
CVD. Most of the available information arises from cross-
sectional studies showing that the severity of CVD is often
thought to be related to the magnitude and distribution of
reflux as well as the length of time it has been present.2,3
Unfortunately, the rate of progression from asymptomatic
evidence of reflux to onset of symptoms that lead to severe
clinical manifestations of CVD, such as skin changes and
ulceration, still remains very poorly defined.4
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900Several risk factors have been associated with the devel-
opment of CVD, including older age,5 female gender,5,6
family history,5,7 standing occupation,8-12 obesity,6,10-12
and multiparity.7,10,12,13 However, other potential factors
that may be involved in CVD progression have not been
well studied, such as estrogen treatment (ET),10,11,14 and
warrant further investigation. On the other hand, although
many studies have shown that elastic compression stockings
are the keystone of CVD treatment in the context of
symptom relief,15 ulcer healing,16 and antithrombotic pro-
phylaxis,17 limited evidence is present on supportive role of
elastic stocking use (ESU) in the inhibition of CVD pro-
gression that is limited mainly to patients with post-throm-
botic etiology.18
Although the advents of color duplex ultrasound
(CDU) imaging and improvements in the classification of
CVD19 have significantly enhanced our current under-
standing of the underlying pathophysiology, studies on the
natural history and progression of CVD are still scarce. This
study was prospectively conducted to determine the pro-
gression of CVD in contralateral untreated limbs of patients
who underwent unilateral varicose vein surgery. More spe-
cifically, we wished to identify changes in the distribution
and extent of reflux as well as changes in clinical manifesta-
s pat
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correlation between CVD progression and the modifica-
tion of specific potential risk factors during the same 5-year
period, such as orthostatism, obesity, ET, multiparity, and
the ESU.
METHODS
Full local ethics committee approval for this study was
obtained from the University of Crete Medical School.
Patient selection. The contralateral asymptomatic or
minimally symptomatic lower limbs of patients who under-
went unilateral surgery for primary varicose veins were
evaluated with clinical and CDU examination, initially dur-
ing the operation and 5 years later. The index procedures,
reasons for intervention, CDU findings, and CVD progres-
sion in the treated limbs were previously reported.20,21
All patients with a history of venous surgery, deep
venous thrombosis, superficial thrombophlebitis, or injec-
tion sclerotherapy were initially excluded. A total of 94
patients (94 limbs; 76 women, 18 men) were assigned to
our follow-up protocol, and 73 patients (73 limbs; 69
women, 4 men), who were a mean age of 48 years (range,
24-78 years), completed our 5-year follow-up protocol.
We excluded 21 patients due to contralateral limb
thrombosis or adjunctive therapies or because patients were
lost during follow-up (Fig 1). Although these events oc-
curred on the operated limbs, these patients were excluded
from further follow-up in accordance with our previously
reported protocol.20,21 The rationale behind the exclusion
of these patients was to evaluate the progression of primary
CVD without including patients with any implication of
possible secondary pathophysiologic causes such as post-
Fig 1. Flowchart showthrombotic events induced by sclerosant agent injection,postoperative immobilization, and surgery-related coagu-
lation changes.
Physical examination and CDU assessment.
Preoperatively and 5 years after surgery, physical examina-
tion and clinical history were focused on the presence,
onset, and duration of CVD symptoms and signs of the
evaluated limbs.
The CDU assessment aimed to detect the presence and
extent of any site of venous reflux. The entire venous system
of the evaluated lower limb was examined from the groin to
the ankle with CDU (Sequoia TM 512, Accuson Corpora-
tion, Mountain View, Calif) using a 4-7 MHz linear array
transducer as previously described.20 The common femo-
ral, femoral, common trunk of the deep femoral, popliteal,
crural, gastrocnemius, great and small saphenous veins and
their branches, as well as the saphenofemoral and saphe-
nopopliteal junctions were examined.
Patients were standing for examination, and the pres-
ence of reflux was assessed using the Valsalva maneuver in
the groin and manual compression with sudden release
distal to the venous segment under investigation. Scanning
in oblique and transverse mode was used for the evaluation
of the perforating veins because the long axis of these
vessels is not detected well in these planes. Augmentation
of blood flow by distal compression of the limbwith sudden
release was used to determine the valvular integrity.
Healthy valves close in about 0.5 second. Retrograde flow
on Doppler recordings that lasted 0.5 second was con-
sidered to indicate the presence of venous reflux. Deep
venous insufficiency was defined as the presence of reflux in
any deep venous segment distal to femoral vein and at least
1 cm away from the saphenofemoral or saphenopopliteal
ient selection process.junctions when there was coexistent reflux at these sites.
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attention was taken to evaluate if the appearance of new
sites of reflux occurred as an extension to pre-existing
incompetent veins in an antegrade or retrograde fashion, or
if this actually represented involvement of new venous
segments without any continuity to formerly incompetent
veins.
Classification. All examined limbs were classified pre-
operatively and 5-years after surgery according to the mod-
ified CEAP scoring system.19 This classification was based
on ultrasound criteria where the superficial and deep ve-
nous systems of the lower limbs were divide into 18 seg-
ments (as proposed by CEAP), which were individually
examined and graded.19,20 By using the information ob-
tained after clinical and ultrasound examination, each limb
was assigned a clinical (C), an anatomic (A), and a disability
(D) score. To compare the preoperative and postoperative
condition of each limb, these scores were added (C  A 
D) to produce a total severity score (CAD). Mean values
were used to observe overall change in the studied limbs.
Modification of predisposing factors. The existence
of positive family history and other factors such as orthos-
tatism prolonged for 4 hours daily,8 obesity, defined as a
body mass index (BMI)30 kg/m2,6 ET,14 and multipar-
ity,13 were considered as predisposing to CVD progression
(Table I). We also documented preoperative ESU. These
parameters were recorded from information that the pa-
tients disclosed during the interview. A record of the pres-
ence or absence of each predisposing factor was performed
after verifying if (1) a history of the predisposing factor
existed at initial examination, (2) was initiated during
follow-up, (3) was maintained during follow-up, or (4) was
terminated during follow-up. BMI was estimated after
weight and height measurements were taken. ET was doc-
umented through the patient’s personal medication log.
ESU and standing time were recorded based on patient
deposition.
After contralateral surgery, patients were recom-
mended to control these risk factors. More specifically,
we suggested avoidance of orthostatism lasting 4 hours
daily in the belief that this might decrease the risk of
recurrence in the operated-on limb. These instructions
were meant to serve as a general guideline to modify the
patient’s standing posture habits. We also recommended
maintaining a BMI 30 kg/m2, discontinuing the use of
Table I. Modification of predisposing factors that were as
Predisposing factor Absent
Elastic stocking use Nondaily use
Daily use but 8 h
Obesity BMI 30 kg/m2
Prolonged orthostatism 4 h continuous standing
Estrogen therapy Negative history
Multiparity (women) History of 2 births
BMI, Body mass index.ET as a contraceptive, and finally, the voluntary managingof more than two births given that this could possibly affect
CVD progression. Systematic ESU was suggested, with a
grading of pressure from 15 to 20 mmHg for a period of 3
months postoperatively and subsequent replacement by
stockings with a grading pressure from 10 to 15mmHg. At
the 5-year follow-up, we assessed the compliance of our
patients with modification of these predisposing factors as
well as with ESU, using the information revealed by the
individual during interview.
Statistical analysis. The information collected was
processed and analyzed using a custom database using SPSS
10.5 software (SPSS Inc, Chicago, Ill). Grouped data are
presented as means standard deviation, and bars in charts
depict averages  standard error. Pearson 2 and paired t
tests were used for estimation of statistical significance
between groups. Correlations between dichotomous or
ordinal variables were judged with the use of Spearman .
Finally, binary logistic regression analysis was used to dis-
criminate between dependent and independent behavioral
factors and coefficients (B) are also presented. Significance
was reached at values of P  .05.
RESULTS
Initial clinical evaluation. Initially, CVD symptoms
were mainly present in limbs that were about to undergo
surgery. Only 5 (7%) of the 73 contralateral limbs included
in our study had symptoms, consisting of mild pain and
heaviness, resulting in a mean preoperative clinical score of
0.1  0.03 (Fig 2). Clinical deterioration of the contralat-
eral limbs according to the CEAP classification, preopera-
tively and after 5-years, is reported in Table II. Of the 73
limbs, 56 (77%) did not have any evidence (symptoms or
signs) of CVD andwere classified as C0, 15 (21%) presented
only telangiectasias or even reticular and spider veins (C1),
and 4 (5%) had small varicosities (C2). None of these
patients had requested any kind of treatment for these
veins, however.
Initial CDU evaluation. It is noteworthy that during
the initial CDU examination, 18 limbs (25%) had reflux
along various segments of the superficial, deep, and perfo-
rator venous system, even though they were mainly asymp-
tomatic and had not presented varicose veins with any
clinical significance. Isolated superficial vein reflux was
present in 12 limbs (16%), but various complex patterns of
superficial, perforator, and deep venous reflux were also
d for each patient
Present
Daily use 8 h
BMI 30 kg/m2
g work 4 h of continuous standing during work
Positive history
History of 2 birthssesse
durinfound among 6 limbs (8%; Table II).
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examination, we found remarkable changes in the anatomic
distribution of reflux among the evaluated limbs. Specifi-
cally, 48 new sites of venous reflux, including 37 (77%) in
the superficial system, 5 (11%) in the perforators, and 6
(13%) in the deep venous system were found in 38 limbs
(52%; Fig 3). The venous segments more commonly af-
fected by new findings were the superficial veins (P .001)
and predominantly the saphenous veins (P  .01; Fig 3).
We found 30 new sites of reflux that were not in continuity
with the pre-existing incompetent veins, whereas the re-
maining 18 extended from formerly incompetent venous
segments, (P  .2). Reflux progression occurred in ante-
grade fashion in 10 of these limbs, and in retrograde fashion
in the other 8 (2  0.01, P  .9). Of the six limbs that
developed deep vein reflux during the 5-year follow-up,
two each developed reflux in the femoral vein, in the
popletial vein, and in the calf veins.
CDU changes and clinical correlations. The docu-
mented changes on follow-up CDU were associated with
clinical deterioration of the affected limbs as summarized in
Tables II and III. In particular, 5 limbs progressed from C0
to C1, 2 from C0 to C3, 5 from C0 to C1,2, 5 from C0 to
C2,3, 6 fromC0 to C1,2,3, 6 fromC1 to C2, 3 fromC1 to C3,
2 from C2 to C2,3, and 2 limbs from C2 to C2,3,4 (Table
III). It is also noteworthy that among the 23 limbs (32%) in
which clinical deterioration was documented by an increase
in the clinical CEAP classification by 2 grades, 18 pre-
sented an extension of the preoperative reflux throughout
the study. This was significantly common compared with
the 5 of 20 limbs (25%) that had presented a similar clinical
worsening but had developed new sites of reflux without
continuity with pre-existing incompetent veins (2  4.4,
P  .05). Of the 18 limbs presenting with an extension of
reflux in pre-existing reflux sites with an increase of their C
Fig 2. Mean CEAP venous severity scores among the evaluated
limbs during the study period. Severity score  clinical score 
anatomic score  disability score. The bars represent standard
error.score by 2 grades during the 5-year follow-up, varicoseveins or edema developed in 16 limbs and dermatosclerosis
in 2.
Furthermore, 30 limbs (41% of the total or 79% of the
limbs that developed new sites of reflux) had various symp-
toms indicative of CVD (Table II), and subsequently, all
the CEAP scores had been broken down significantly (Fig
2). Positive family history for venous diseases was more
common among the 38 aforementioned limbs with pro-
gression of CVD, 32 (84%) vs 6 (16%; 2 11, P .001).
CVD progression and behavioral modifications.
Patient fulfillment of our postoperative directions for mod-
ification of CVD predisposing factors during the follow-up
period was low (Table IV). Similarly, compliance with ESU
was also limited. However, after correlating the modifica-
tion of risk factors and compliance with ESU in limbs with
extension of pre-existent or new sites of reflux, or both, we
found that patients who did not report orthostatism preop-
eratively and during the study, or who managed to control
it, had a significantly lower incidence of CVD progression
compared with those who maintained preoperative ortho-
statism or initiated it during the study (P .001; Table V).
The incidence of CVD progression was significantly
lower in patients who were not obese preoperatively and
did not become obese during the study or controlled their
preoperative obesity compared with those who become
obese during the study period or maintained their preop-
erative obesity (P  .001). In addition, patients who had
not adopted ESU preoperatively and during the follow-up
period or had adopted ESU but stopped using it had a
significantly higher incidence of CVD progression com-
pared with those who started ESU during the study or
continued their preoperative use (P 7 10	9; Table V).
In contrast, no correlation was found for CVD progres-
sion between women who continued or started ET (67%)
and those who stopped ET during the study or had not ever
taken ET (P  .97; Table V). Furthermore, women with
less than two births preoperatively or even during the study
did not have any significant difference in CVD progression
compared with those who completed or hadmore than two
births during the study and preoperatively, respectively
(P  .76; Table V).
Binary logistic regression analysis provided evidence on
whether the behavioral modifications tested could be con-
sidered independent variables for prediction of CVD pro-
gression. Orthostatism (P  .002) and obesity (P  .009)
were the main independent predictive factors for CVD
progression (B coefficient values 1.745 and 1.602, respec-
tively). ESU was the third independent (P .037) but less
potent (B  0.947) factor. In contrast, multiparity (P 
.17) and ET (P .43) were not independent risk factors for
CVD progression.
DISCUSSION
Even though primary CVD is one of the commonest
vascular disorders,1 its natural history still remains poorly
understood because only a few longitudinal studies have
evaluated the characteristics as well as the factors responsi-
ble for disease progression.22 Most of the available infor-
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CVD is a generalized disease with multifactorial etiology
and developmental origin in the preliminary stages, of
Table III. Changes in the clinical classification (C) of
the limbs, according to CEAP, at the initial and 5-year
follow-up examination
C at 5 years
C initially C1 C2 C3 C1,2 C2,3 C1,2,3 C2,3 C2,3,4
C0 5 . . . 2
a 5a 5a 6a . . . . . .
C1 . . . 6 3
a . . . . . . . . . . . . . . .
C2 . . . . . . . . . . . . . . . . . . 2 2
a
aRefers to limbs presenting deterioration in the clinical score of2 or more
grades.
Table II. Initial and 5 years of follow-up classification of l
C No. (%)a E No. (%)a
Initial
0 56 (77) EC 0 (0)
1 15 (21) EP 18 (25)
2 4 (5) ES 0 (0)
3 0 (0) EPS 0 (0)
4 0 (0)
5 0 (0)
6 0 (0)
5-y follow-up
0 37 (51) EC 0 (0)
1 31 (43) EP 38 (52)
2 26 (36) ES 0 (0)
3 20 (27) EPS 0 (0)
4 2 (3)
5 0 (0)
6 0 (0)
aC, Clinical classification; E, etiologic classification (EC, congenital; EP, prim
deep); P, pathophysiologic classification (R, reflux; O, obstruction).
aNumber (%) of limbs.
Fig 3. Anatomic distribution of color duplex ultrasound changes is
shown. Deep, Deep veins; GSV, great saphenous vein;NSV, nonsaphe-
nous veins; SSV, small saphenous vein;Perf,perforators veins.*Superficial
veins vs any other veins separately (2  28; P  .001). **Saphenous
veins vs any other superficial veins separately (2 7; P .01). ***Ex-
tension vs new sites of reflux (2 1.5; P .2).which various segments of the lower limb venous systemscould be involved, presenting reflux on CDU examina-
tion.2,3,23,24 The time-cross correlation between ultra-
sound evidence of reflux and development of clinical signs
or even symptoms of CVD is poorly evaluated, however,
because the progress of venous reflux is not always related
with the manifestation of relevant symptoms or signs.
Sarin et al25 evaluated for a median of 20 months 36
patients (56 limbs) in whom varicose vein surgery differed.
New segmental reflux was seen in 18% of those initially
affected and in 25% of initially healthy limbs, new varicos-
ities developed in 5 of 16 (31%) previously healthy con-
tralateral limbs, new lipodermatosclerosis developed in 1 of
50 limbs at risk, and no limb had a new ulcer.
Another cross-sectional prospective study22 investigat-
ing 90 patients (116 limbs) found that 31 of the evaluated
limbs (27%) had documented ultrasound evidence of dis-
ease progression, 13 (11%) had progression of clinical stage
(7 from C2 to C3, 4 from C3 to C4, and 2 from C4 to C6),
and 7 had progression on CDU as well. The great saphe-
nous vein and tributaries were themost often anatomic sites
according to basic CEAPa in 73 limbs
A No. (%)a P No. (%)a
AS 12 (16) R 18 (25)
ASP 2 (3) O 0 (0)
AP 0 (0) R  O 0 (0)
ASD 2 (3)
AD 0 (0)
ASPD 2 (3)
AS 24 (33) R 38 (52)
ASP 4 (5) O 0 (0)
AP 0 (0) R  O 0 (0)
ASD 5 (7)
AD 0 (0)
ASPD 5 (7)
S, secondary); A, anatomic classification (AS, superficial; AP, perforator; AD,
Table IV. Modification of chronic venous disease
progression, predisposing factors, and compliance with
elastic stocking use during the studya
Variable
Initially 5 years
PbNo. (%)c No. (%)c
Prolonged orthostatism 44 (60) 47 (64) .9
Obesity 48 (66) 53 (73) .7
Estrogen treatment 4 (5) 5 (7) .3
Multiparity 4 (5) 7 (10) .4
Elastic stocking use 34 (46) 24 (33) .3
aForty-eight patients (66%) had a known family history of chronic venous
disease.
bPearson 2.
cNumber (%) of patients.imbs
ary; Eaffected by CVD progression, followed by perforators.
time o
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the evaluated limbs, and 12% had reflux in a new segment.
Our current study revealed an incidence of venous
reflux progression almost double, or more than double,
compared with these studies. Specifically, we found devel-
opment of new sites of reflux in 52% of the studied limbs, in
contrast to 25% and 18% found by Sarin et al25 among the
initially healthy and symptomatic limbs of their study,
respectively. In this context, Labropoulos et al22 reported a
27% rate of venous reflux progression among their studied
limbs.
The differences between our study and these other
studies22,25 are most likely due to the different number of
studied limbs, the shorter follow-up period, and dissimilar
CVD severity of the evaluated limbs, since these studies
included symptomatic patients belonging to advanced
CEAP classes. Our study, in contrast, included patients
who underwent unilateral varicose vein surgery but simul-
taneously presented with an almost asymptomatic con-
tralateral limb (95% of the limbs were C0,1 A; Table II),
giving us the prospective of evaluating the rate and se-
quence of CVD progression starting from early, preclinical
stages. In addition, the probable explanation for the de-
creased rate of reflux progression among the symptomatic
limbs of these two studies was that these limbs had already
developed, at the time of first examination, many sites of
reflux resulting in a significant reduction of the total num-
ber of veins that were amendable to further CVD progres-
Table V. Correlations between modification of chronic ve
elastic stocking use in limbs that developed new sites of refl
Variables
CVDP (–)
No. (%)a
Prolonged orthostatism
Absent initially & DFP 17 (49)
Controlled DFP 7 (20)
Initiated DFP 3 (9)
Maintained DFP 8 (22)
Obesity
Absent initially & DFP 9 (26)
Controlled DFP 9 (26)
Initiated DFP 4 (11)
Maintained DFP 13 (37)
Elastic stockings use
Maintained DFP 17 (48)
Initiated DFP 3 (9)
Stopped DFP 6 (17)
Absent initially & DFP 9 (26)
Estrogen treatment
Absent initially & DFP 32 (91)
Controlled DFP 1 (3)
Initiated DFP 1 (3)
Maintained DFP 1 (3)
Multiparity
Absent initially & DFP 32 (91)
Initiated DFP 1 (3)
Maintained DFP 2 (6)
CVDP(), Limbs with ultrasound-proven chronic venous disease prog
progression; DFP, during follow-up period; Initially, initial examination at
aNumber (%) of limbs.sion.This study showed that superficial veins, and particu-
larly the saphenous systems, were the more commonly
affected veins for the development of new sites of reflux.
This is in accordance with other studies where the superfi-
cial venous system, and particularly the tributaries and the
main trunk of great saphenous vein, is predominantly af-
fected by CVD.3,24,26 In addition, we found that venous
reflux extended in an antegrade or retrograde fashion and
could occur in continuity with pre-existing incompetent
sites.
Reflux could also develop in new locations, indepen-
dent of the pre-existing diseased sites, which contradicts
traditional knowledge that primary reflux starts at the sa-
phenofemoral junction level and proceeds in a retrograde
manner. However, other studies have previously shown
that reflux can develop without junctional involvement,
often disturbing different veins that may communicate with
each other.3,22-24 The current study supports these findings
and designates that reflux in the context of primary CVD
may involve any segment of the lower limb venous systems
in a retrograde or antegrade manner.
Even though most of the limbs evaluated in our study
were asymptomatic (CEAP stages 0 and 1), the initial CDU
examination found about a quarter of these had various
sites of reflux along their venous systems. These findings are
in agreement with previous reports which found that
CDU evidence of reflux in preliminary stages of CVD is
not always associated with clinical manifestations such as
disease progression risk factors and compliance with
CVDP ()
2 PNo. (%)a
49.2  .001
0
2 (5)
9 (24)
27 (71)
28.3  .001
1 (3)
1 (3)
11 (29)
25 (65)
40.9  .001
3 (8)
1 (3)
8 (21)
26 (68)
0.226 .97
34 (88)
1 (3)
2 (6)
1 (3)
0.562 .76
34 (88)
2 (6)
2 (6)
n; CVDP(–), limbs without ultrasound-proven chronic venous disease
f contralateral limb surgery.nous
ux
ressioedema, varicose veins, or skin changes and ulcer-
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tinuous development of new sites of reflux among the
evaluated limbs resulted in a remarkable clinical deteriora-
tion, given that about one-third of the initially asymptom-
atic limbs had progression of more than one stage of the
CEAP clinical classification (Tables II and III).
In addition, the clinical deterioration was illustrated by
the significant increase of all the components of the CEAP
severity score (Fig 2). It is also noteworthy, that the exten-
sion of the venous reflux significantly correlated with the
clinical worsening of the evaluated limbs, because all of the
limbs with extended pre-existing venous reflux clinically
deteriorated by increasing the CEAP class by more than
one CEAP clinical step. On the other hand, only one-
quarter of the limbs that developed new sites of reflux,
without any continuity with incompetent veins at preoper-
ative CDU, presented a similar clinical deterioration. These
results can be linked to the conclusions reported by Labro-
poulos et al,2 who showed that the clinical manifestations in
patients with CVD are dependent on the pattern and
extension of reflux as well as the duration of disease, imply-
ing that the severity of clinical presentation in CVDmay be
time-dependent.
Several factors have been suggested to be important in
the development of CVD.5-14 The importance of some of
these are well established, whereas others remain contro-
versial.9-14 Most of the available information arises from
cross-sectional surveys with target populations, but evi-
dence from longitudinal studies still remains limited.5 An-
other major methodologic issue in regard to these studies is
the improper control of the potential predisposing factors.5
Most investigators attempted to adjust or to stratify for age
or gender, or both, in estimates of prevalence for measures
of association with various risk factors of interest. More
recent studies have used more sophisticated multivariate
logistics to simultaneously adjust for multiple predisposing
factors. Despite the aforementioned limitations, most in-
vestigators agree that a positive family history for CVD,
female gender, standing occupations, obesity, and multi-
parity may significantly influence CVD development.5-14
In contrast, the importance of other factors such as ESU,
oral contraceptives, constipation or low fiber intake, smok-
ing, hypertension, and physical activity are considered con-
troversial.5,10,11,14
At the beginning of this study, a positive family history,
female gender, obesity, an occupation with prolonged
standing, and limited ESU were dominant among the
evaluated patients, thus offering the opportunity to pro-
spectively evaluate their potential influence of CVD pro-
gression. Five years later, we found limited patient compli-
ance with our postoperative directives for CVD risk factor
modification of prolonged orthostatism, obesity, ET, mul-
tiparity, and ESU, resulting in significant clinical and ultra-
sound CVD progression of the evaluated limbs. CVD
progression was related to the patients’ inability to control
three specific factors: prolonged orthostatism, obesity, and
compliance with ESU. These results are in agreement with
those of large epidemiologic studies5-14 that identify similarlifestyle factors that predispose to CVD development and
support the significance of the aforementioned common
behavioral factors to progression of venous disease. In
contrast, a history of multiparity or ET, although consid-
ered initially as suspect, had not been proven to be inde-
pendent risk factors of CVD. This result probably indicates
that in contrast to commonly held beliefs, their effect on
CVD progression is limited.
After evaluating the data obtained from this study, we
believe that modification of these predisposing factors for
CVD may reduce the risk of recurrence in unilateral oper-
ated-on limbs and may reduce CVD progression in the
contralateral limbs. We have used these findings to alter the
discharge instructions for patients after varicose vein sur-
gery to follow these lines. Furthermore, we are currently
submitting a revisal protocol to obtain funding to continue
the follow-up of these patients for 10 years with the belief
that the number of patients with initially asymptomatic or
minimally symptomatic CVD who will show disease pro-
gression will further increase.
This study has some limitations. This select group of
patients was known to be prone to primary superficial
venous insufficiency, so the extent to which we can extrap-
olate our results to the general population may be limited.
Of course, it is from this group that we aimed to better
compare the natural history of the disease and to identify
the predisposing factors, which if modified, will result in
better patient care.
This is not a population-based longitudinal study that
was powered to answer the effect of behavioral modifica-
tions on the development and progression of CVD, and
subsequently, our findings cannot be applied to all patients
with CVD. Therefore, prospective long-term studies with
large samples should be induced to precisely evaluate the
characteristics and the responsible factors of the progres-
sion of this disease.
Monitoring compliance to predisposing factor modifi-
cation relied on data derived from patient interviews during
initial and 5-year follow-up examination. Although weight
measurements, ET, and multiparity may be documented
with accuracy, standing time and ESU may not. How long
a patient uses elastic stockings or how long they stand is of
course a crude patient-reported estimate, so there is no
specific way to exactly monitor this variable, especially for a
period of 5 years. Other epidemiologic studies have also
faced this problem. Gourgou et al8 considered patients
positive for orthostatism when they reported standing
for 4 hours daily during work. Furthermore, even the
authors of CEAP,19 as well as a newer modification,29
estimate the severity score by using patient-reported
information and do not use elaborate monitoring tech-
niques.
CONCLUSION
Our study shows that about a half of our patients with
unilateral varicosities could potentially develop CVD pro-
gression in the initially asymptomatic contralateral limb.
Progression of CVD included anatomic extension of reflux
JOURNAL OF VASCULAR SURGERY
Volume 51, Number 4 Kostas et al 907as well as development of reflux in new venous segments
accompanied by clinical deterioration. Clinical manifesta-
tions of CVD seem to correlate more commonly with the
extension of reflux along the various venous segments
rather than with the development of new sites.
Finally, we found that prolonged orthostatism, obesity,
and low compliance with elastic stocking use are indepen-
dent risk factors that may influence CVD progression. In
contrast, it seems that multiparity and estrogen treatment
do not have an effect on CVD progression. Therefore,
maintenance of a normal body weight, limitation of pro-
longed orthostatism, and systematic elastic stocking use
may be recommended in patients with CVD to limit future
disease progression.
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